文献速递前列腺癌

局部麻醉下经会阴前列腺穿刺活检的非感染性不良事件

Non-infectious adverse events of transperineal prostate biopsies performed under local anaesthesia.
PubMed 文献 · BJU Int · 2024-04-28

本研究为前瞻性NORAPP研究挪威分支的次要结局报告,纳入2019年11月至2021年2月转诊行前列腺穿刺的402例患者,在门诊局麻下行经会阴MRI-经直肠超声融合穿刺活检。中位VAS疼痛评分在局麻置入时、穿刺中及穿刺后分别为1、1、0,血尿发生率64%(95%CI 60-69%),急性尿潴留发生率0.5%(95%CI 0.1-1.8%),无患者住院或需穿刺后外科干预。

要点

  • 局麻下经会阴前列腺穿刺活检患者不适感有限,中位VAS疼痛评分穿刺中为1分。
  • 血尿发生率为64%(95%CI 60-69%),急性尿潴留发生率为0.5%(95%CI 0.1-1.8%)。
  • 无患者因穿刺后不良事件住院或需外科干预。

核心结论

  • 经会阴前列腺穿刺活检可在局麻下进行,患者不适感有限且穿刺后不良事件少。

研究设计与样本

  • 本研究为前瞻性NORAPP研究(ClinicalTrials.gov标识NCT04146142)挪威分支的次要结局报告,纳入2019年11月至2021年2月所有转诊行前列腺穿刺的患者,共402例,采用门诊局麻下经会阴MRI-经直肠超声融合穿刺活检,随访采用患者报告问卷在穿刺后即刻、2周和2个月进行。

主要发现

  • 共纳入402例患者,应答率99.8%(401/402),中位(四分位距[IQR])年龄69(63-74)岁,前列腺体积40(27-58)mL,前列腺特异性抗原水平7.0(4.5-11)ng/mL,穿刺针数8(6-10)针。
  • 中位(IQR)VAS疼痛评分在局麻置入时为1(1-2),穿刺中为1(0-2),穿刺后为0(0-0)。
  • 血尿发生率为64%(95%CI 60-69%),急性尿潴留发生率为0.5%(95%CI 0.1-1.8%)。
  • 无患者住院或需穿刺后外科干预。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To report non-infectious adverse events associated with transperineal prostate biopsy (TPBx) performed under local anaesthesia (LA) in an outpatient setting. PATIENTS AND METHODS: This study reports secondary outcomes from the Norwegian arm of the prospective NORAPP study (ClinicalTrials.gov identifier NCT04146142) and included all patients referred for prostate biopsy from November 2019 to February 2021. Transperineal magnetic resonance imaging-transrectal ultrasonography fusion TPBx were taken using 40 mL 1% lidocaine with 4 mL of 8.4% sodium bicarbonate placed in the perineal skin, under the prostatic apex, in the m. levator ani bilaterally, and along the path of the needle. Follow-up using patient-reported questionnaires was done immediately after TPBx, and after 2 weeks and 2 months. Pain was reported using a visual analogue scale (VAS) during placement of the LA, and during and after TPBx. Haematuria and acute urinary retention (AUR) rates were recorded. RESULTS: We included 402 patients, and the response rate was 99.8% (401/402). The median (interquartile range [IQR]) age was 69 (63-74) years, the prostate volume was 40 (27-58) mL, the prostate-specific antigen level was 7.0 (4.5-11) ng/mL, and the number of biopsy cores taken was 8 (6-10). The median (IQR) VAS pain score was 1 (1-2) during placement of LA, 1 (0-2) during TPBx, and 0 (0-0) after TPBx. Haematuria and AUR rates were 64% (95% confidence interval [CI] 60-69%) and 0.5% (95% CI 0.1-1.8%), respectively. No patients were hospitalised or required after the TPBx surgical intervention. CONCLUSION: Transperineal prostate biopsies can be performed under LA with limited discomfort to the patient and few post-TPBx adverse events.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Jacewicz M, Rud E, Lauritzen P, et al. Non-infectious adverse events of transperineal prostate biopsies performed under local anaesthesia. BJU Int. 2024. PMID: 38679416. doi:10.1111/bju.16383

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。